Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Incyte Corp (INCY)  
$105.92 4.65 (4.21%) as of 4:30 Thu 1/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 219,000,000
Market Cap: 23.20(B)
Last Volume: 2,578,081 Avg Vol: 1,755,750
52 Week Range: $55.17 - $108.26
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  235
Guru Rank Value     : 6.7
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 303,540 336,856 407,211 484,528
Total Sell Value $31,270,559 $33,651,965 $38,573,535 $43,581,118
Total People Sold 7 9 9 10
Total Sell Transactions 17 31 41 54
End Date 2025-10-11 2025-07-10 2025-01-09 2024-01-10

   
Records found: 1084
  Page 1 of 44  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Issa Mohamed Khairie EVP, Head of US Oncology   •       –      –    2026-01-07 4 S $109.07 $1,184,064 D/D (10,856) 66,132     -
   Issa Mohamed Khairie EVP, Head of US Oncology   •       –      –    2026-01-06 4 D $106.66 $881,438 D/D (8,264) 76,988     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2026-01-05 4 S $101.70 $1,589,978 D/D (15,634) 34,203 -9%     
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2025-12-31 4 D $98.77 $1,312,851 D/D (13,292) 49,837     -
   Baker Julian   –       •       •   2025-12-31 4 A $0.00 $0 I/I 656 28,188,297     -
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2025-12-31 4 D $98.77 $25,088 D/D (254) 27,253     -
   Harrigan Edmund Director   –       •      –    2025-12-31 4 A $98.77 $24,199 D/D 245 20,853     -
   Clancy Paul J Director   –       •      –    2025-12-31 4 A $98.77 $23,804 D/D 241 23,476     -
   Tray Thomas Principal Accounting Officer   •       –      –    2025-12-19 4 S $100.00 $277,400 D/D (2,774) 22,973 -8%     
   Tray Thomas Principal Accounting Officer   •       –      –    2025-12-19 4 OE $95.76 $265,638 D/D 2,774 25,747     -
   Tray Thomas Principal Accounting Officer   •       –      –    2025-12-18 4 S $98.25 $58,950 D/D (600) 22,973 -14%     
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2025-12-17 4 S $97.26 $420,455 D/D (4,323) 27,507 -13%     
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2025-12-16 4 S $97.29 $5,254,547 D/D (54,008) 31,830 -14%     
   Mayes Patrick A EVP & Chief Scientific Officer   •       –      –    2025-12-11 4 S $94.94 $24,210 D/D (255) 60,011 -15%     
   Mayes Patrick A EVP & Chief Scientific Officer   •       –      –    2025-12-10 4 S $95.58 $530,756 D/D (5,553) 60,266 -16%     
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2025-12-02 4 S $102.51 $2,060,964 D/D (20,105) 63,129 -9%     
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2025-12-01 4 D $102.04 $1,744,170 D/D (17,093) 83,234     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2025-12-01 4 S $102.96 $263,475 D/D (2,559) 100,327 -8%     
   Morrissey Michael James EVP, Head of Tech. Operations   •       –      –    2025-12-01 4 D $102.04 $33,265 D/D (326) 85,838     -
   Hoffman Richard A. EVP & General Counsel   •       –      –    2025-12-01 4 A $0.00 $0 D/D 9,466 9,466     -
   Tray Thomas Principal Accounting Officer   •       –      –    2025-11-24 4 S $103.00 $61,800 D/D (600) 23,573 -4%     
   Tray Thomas Principal Accounting Officer   •       –      –    2025-11-21 4 S $102.00 $17,238 D/D (169) 24,173 -8%     
   Denton Sheila A. EVP & General Counsel   •       –      –    2025-11-17 4 S $104.36 $29,012 D/D (278) 26,569 -6%     
   Denton Sheila A. EVP & General Counsel   •       –      –    2025-11-17 4 OE $64.25 $17,862 D/D 278 26,847     -
   Hoppenot Herve Director   –       •      –    2025-11-10 4 S $105.46 $19,773,750 D/D (187,500) 329,646 -4%     
  1084 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 44
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us